Attributions of Change and Self-Efficacy in a Randomized Controlled Trial of Medication and Psychotherapy for Problem Drinking

Behavior Therapy

Volumn 44, Issue 1, 2013, Pages 88-99

  Schaumberg, Katherine ^a   Kuerbis, Alexis ^a   Morgenstern, Jon ^a   Muench, Frederick ^a  

^a Department of Medicine   (United States)

Author keywords

Attributions; Cognitive behavioral therapy; Naltrexone; Self efficacy

Indexed keywords

NALTREXONE; PLACEBO;

ADULT; AGED; ALCOHOL CONSUMPTION; ALCOHOLISM; ARTICLE; ATTITUDE TO CHANGE; COGNITIVE THERAPY; DIARRHEA; DRUG DOSE TITRATION; FATIGUE; HEALTH STATUS; HUMAN; INSOMNIA; LIBIDO DISORDER; LONG TERM CARE; MALE; MOTIVATIONAL INTERVIEWING; NAUSEA; PATIENT ASSESSMENT; PATIENT ATTITUDE; PATIENT COMPLIANCE; PSYCHOTHERAPY; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SECONDARY ANALYSIS; SELF CONCEPT; SELF EVALUATION; TREATMENT DURATION; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; ALCOHOLISM; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; DOUBLE-BLIND METHOD; HOMOSEXUALITY, MALE; HUMANS; MALE; MIDDLE AGED; MOTIVATIONAL INTERVIEWING; NALTREXONE; NARCOTIC ANTAGONISTS; SELF EFFICACY; TREATMENT OUTCOME;

EID: 84872287893     PISSN: 00057894     EISSN: 18781888     Source Type: Journal    
DOI: 10.1016/j.beth.2012.07.001     Document Type: Article

References (39)

1. Annis H.M., Graham J.M. The Situational Confidence Questionnaire (SCQ-39) user's guide 1988, Addiction Research Foundation of Ontario, Toronto, Ontario, Canada.
2. Anton R.F., O'Malley S.S., Ciraulo D.A., Cisler R.A., Couper D., Donovan D.M., et al. Combined pharmacotherapies and behavioral interventions for alcohol dependence. Journal of the American Medical Association 2006, 295:2003-2017.
3. Antonuccio D.O., Danton W.G., DeNelsky G.Y. Psychotherapy versus medication for depression: Challenging the conventional wisdom with data. Professional Psychology: Research and Practice 1995, 26:574-585.
4. Bandura A. Self-efficacy: The exercise of control 1997, Freeman, New York.
5. Barlow D.H., Gorman J.M., Shear M.K., Woods S.W. Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: A randomized controlled trial. Journal of the American Medical Association 2000, 283:2529-2536.
6. Basoglu M., Marks I.M., Killic C., Brewin C.R., Swinson R.P. Alprazolam and exposure for panic disorder with agoraphobia: Attribution of improvement to medication predicts subsequent relapse. British Journal of Psychiatry 1994, 164:652-659.
7. Biondi M., Picardi A. Attribution of improvement to medication and increased risk of relapse of panic disorder with agoraphobia. Psychotherapy and Psychosomatics 2003, 72:110-111.
8. Carroll K.M., Nich C., Sifry R.L., Nuro K.F., Frankforter T.L., Ball S.A.,..., Rounsaville B.J. A general system for evaluating therapist adherence and competence in psychotherapy research in the addictions. Drug and Alcohol Dependence 2000, 57:225-238.
9. Charney D.A., Zikos E., Gill K.J. Early recovery from alcohol dependence: factors that promote or impede abstinence. Journal of Substance Abuse Treatment 2010, 38:42-50.
10. Cohen J. Statistical power analysis for the behavioral sciences 1988, Lawrence Earlbaum Associates, Hillsdale, N.J. 2nd ed.
11. Cottler L.B., Robins L.N., Helzer J.E. The reliability of the Composite International Diagnostic Interview Substance Abuse Module (CIDI-SAM): A comprehensive substance abuse interview. British Journal of Addiction 1989, 84:801-814.
12. DiClemente C.C., Fairhurst S.K., Piotrowski N.A. Self-eficacy and addictive behaviors. Self-efficacy, adapatation, and adjustment: Theory, research and application 1995, 109-141. Plenum, New York. J.E. Maddux (Ed.).
13. Fals-Stewart W., O'Farrell T.J., Freitas T.T., McFarlin S.K., Rutigliano P. The Timeline Followback reports of psychoactive substance use by drug-abusing patients: Psychometric properties. Journal of Consulting and Clinical Psychology 2000, 68:134-144.
14. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Interview for DSM-IV Axis I Disorders, Clinician Version (SCID-CV) 1996, American Psychiatric Press, Inc., Washington, D.C.
15. Foa E.B., Liebowitz M.R., Kozak M.J., Davies S., Campeas R., Franklin M.E. Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder. American Journal of Psychiatry 2005, 162:151-161.
16. Folstein M.F., Folstein S.E., McHugh R.R. Mini-mental state: A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research 1975, 12:189-198.
17. Goldbeck R., Myatt P., Aitchison T. End of treatment self-efficacy: A predictor of abstinence. Addiction 1997, 92:313-324.
18. Hartzler B., Witkiewitz K., Villarroel N., Donovan D. Self-efficacy change as a mediator of associations between therapeutic bond and one-year outcomes in treatments for alcohol dependence. Psychology of Addictive Behaviors 2011, 25:269-278.
19. Hettema J., Steele J., Miller W.R. Motivational interviewing. Annual Review of Clinical Psychology 2005, 1:91-111.
20. Ilgen M., McKellar J., Tiet Q. Abstinence self-efficacy and abstinence 1 year after substance use disorder treatment. Journal of Consulting and Clinical Psychology 2005, 73:1175-1180.
21. Kranzler H.R., Armeli S., Feinn R., Tennen H. Targeted naltrexone treatment moderates the relations between mood and drinking behavior among problem drinkers. Journal of Consulting and Clinical Psychology 2004, 72:317-327.
22. Ledgerwood D.M., McCaul M.E., Petry N.M. Psychotherapy and pharmacotherapy in treatment of substance use disorders. Clinical manual of addiction psychopharmacology 2005, 339-363. American Psychiatric Publishing, Inc., Arlington, VA. H.R. Kranzler, D.A. Ciraulo (Eds.).
23. Madson M.B., Campbell T.C. Measures of fidelity in motivational enhancement: A systematic review. Journal of Substance Abuse Treatment 2006, 31:67-73.
24. Marks l., Swinson R.P., Basoglu M., Kuck K., Noshirvani H., Sullivan G. Alprazolam and exposure alone and combined in panic disorder with agoraphobia: A controlled study in London and Toronto. British Journal of Psychiatry 1993, 162:776-787.
25. McCaul M.E., Wand G.S., Stauffer R., Lee S.M., Rohde C.A. Naltrexone dampens ethanol-induced cardiovascular and hypothalamic-pituitary-adrenal axis activation. Neuropsychopharmacology 2001, 25:537-547.
26. Morgenstern, J., Kuerbis, A., Kahler, C. W., Bux, D. A., & Kranzler, H. (In press). Testing naltrexone and behavioral therapy for problem drinking men-who-have-sex-with-men. Journal of Consulting and Clinical Psychology.
27. Muench F., Blain L., Morgenstern J., Irwin T.W. Self-efficacy and attributions about change in persons attempting to reduce compulsive sexual behavior with medication vs. placebo. Sexual Addiction & Compulsivity 2011, 18:232-242.
28. Morgenstern J., Irwin T.W., Wainberg M.L., Parsons J.T., Muench F., Bux D.A., et al. A randomized controlled trial of goal choice interventions for alcohol use disorders among men-who-have-sex-with-men. Journal of Consulting and Clinical Psychology 2007, 75:72-84.
29. Morgenstern J., McKay J. Rethinking the paradigms that inform behavioral treatment research for substance use disorders. Addiction 2007, 102:1377-1389.
30. Morin C.M., Colecchi C., Stone J., Sood R., Brink D. Behavioral and pharmacological therapies for late-life insomnia: A randomized controlled trial. Journal of the American Medical Association 1999, 281:991-999.
31. O'Malley S.S., Jaffe A.J., Chang G., Rode S., Schottenfeld R., Meyer R.E., et al. Six-month follow-up of naltrexone and psychotherapy for alcohol dependence. Archives of General Psychiatry 1996, 53:217-224.
32. O'Malley S.S., Jaffe A.J., Chang G., Schottenfeld R.S., Meyer R.E., Rounsaville B.J. Naltrexone and coping skills therapy for alcohol dependence: A controlled study. Archives of General Psychiatry 1992, 49:881-887.
33. Powers M.B., Smits J.A., Whitley D., Bystritsky A., Telch M.J. The effect of attributional processes concerning medication taking on return of fear. Journal of Consulting and Clinical Psychology 2008, 76:478-490.
34. Sanchez-Craig M., Annis H.M., Bornet A.R., MacDonald K.R. Random assignment to abstinence and controlled drinking: Evaluation of a cognitive-behavioral program for problem drinkers. Journal of Consulting and Clinical Psychology 1984, 52:390-403.
35. Schwarzer R., Fuchs R. Self-efficacy and health behaviors. Predicting health behavior 1996, 163-196. Open University Press, Buckingham. M. Conner, P. Norman (Eds.).
36. Vielva I., Iraugi I. Cognitive and behavioural factors as predictors of abstinence following treatment for alcohol dependence. Addiction 2001, 96:297-303.
37. Volpicelli J.R., Alterman A.I., Hayasguda M., O'Brien C.P. Naltrexone in the treatment of alcohol dependence. Archives of General Psychiatry 1992, 49:876-880.
38. Witkiewitz K., Donovan D.M., Hartzler B. Drink refusal training as part of a combined behavioral intervention: Effectiveness and mechanisms of change. Journal of Consulting and Clinical Psychology 2012, 80:440-449.
39. Zweben A. Integrating pharmacotherapy and psychosocial interventions in the treatment of individuals with alcohol problems. Journal of Social Work Practice in the Addictions 2001, 1:65-80.